US+1 646-781-8004
Europe+44-203-868-8738
APAC+91-744-778-0008
sales@meticulousresearch.com
Resources 
    • About Us 

    • Home Report Store Digital Biomanufacturing Market
    Digital Biomanufacturing Market

    Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin] Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2031

    Report ID:MRHC - 1041288 Pages: 300 Jul-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours

    Digital Biomanufacturing Market Size & Forecast

    The Digital Biomanufacturing Market is projected to reach $50.89 billion by 2031 at a CAGR of 13.3% from 2024 to 2031. The growth of this market is attributed to various factors such as growing demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased need for process optimization, growing focus on quality standards & regulatory compliance, strong R&D pipeline for biopharmaceuticals, and rising emphasis on continuous bioprocessing. Additionally, the introduction of Industry 4.0, availability of advanced data analysis tools, and shift towards bioprocessing 4.0 are expected to offer growth opportunities.

    Digital Biomanufacturing Market Growth Drivers

    Need for Process Optimization in Biomanufacturing

    Process optimization involves improving manufacturing by incorporating quality monitoring, machinery, and maintenance, among other factors, to optimize costs and increase productivity. The biomanufacturing process is enhanced by process optimization through the identification and resolution of bottlenecks and the assurance of product quality. Process optimization techniques like design of experiments (DoE), statistical process control (SPC), and process analytical technology (PAT), assist biomanufacturers in reducing manufacturing costs and time for the biologics production by incorporating real time monitoring, continuous processing, and data capturing & analysis.

    Biomanufacturing is an expensive method due to the need for specific culture conditions, costly media, and feed. The rising preference for biopharmaceuticals is driving the increased need for process optimization to achieve better yield and product quality. Thus, to scale up the business and to meet growing market demand biopharmaceutical manufacturers are increasing the adoption of process optimization techniques.

    Digital Biomanufacturing Market

    Click here to: Get Free Sample Pages of this Report

    Rising Focus on Continuous Bioprocessing 

    The adoption of continuous bioprocessing is being driven by the rising demand for biopharmaceuticals, supportive global initiatives for their adoption, and the advantages of continuous bioprocessing over traditional batch processing. Continuous bioprocessing facilities are at least 70% smaller than batch production facilities, leading to reduced operating costs. Additionally, continuous bioprocessing alleviates bottlenecks in the manufacturing process, which increases production efficiency and, consequently, lowers the price of biopharmaceuticals.

    Government initiatives, supporting the adoption of biopharmaceuticals, are driving the demand for continuous bioprocessing. For instance, in September 2022, the U.S. government announced an investment of USD 2 billion in a biomanufacturing initiative aimed at expanding and improving the domestic biopharmaceutical manufacturing capacity. The benefits of continuous bioprocessing, such as shorter product development times and enhanced process design flexibility, are driving its increasing adoption.

    Digital Biomanufacturing Market Trends

    Digital Twin Technology

    Digital twin technology helps in predicting and optimizing maintenance for biomanufacturing process and facilities. It provides real-time visualization of products, processes, and their performances. This technology enables real-time monitoring through simulation, ensuring product quality and cost reduction by identifying defects in the ongoing manufacturing process. This enhances manufacturing planning and risk analysis.

    Digital twin technology ensures that the planned process is proceeding as intended, maintaining time efficiency and process optimization through the implementation of effective strategies. For instance, Dassault Systèmes SE (France) offers a Virtual Twin for the biomanufacturing industry. The product provides a digital replica of the pharmaceutical process to optimize and predict the biomanufacturing process. It also helps in the resource planning, building manufacturing plants, simulating & analyzing production scenarios, and unify manufacturing operations.

    Integration of Artificial Intelligence (AI) & Machine Learning (ML)

    Integration of advanced technologies like AI & ML improves monitoring and controlling of the entire manufacturing process. AI & ML assist in drug discovery, design & development, as well as planning and monitoring product quality. They enhance process optimization and resource management throughout the process. AI helps in structuring data and workflow of the machines & equipment involved in the manufacturing process.

    ML helps in various processes like design and planning of biologics, connecting it to actual manufacturing process, and increasing efficiency of working models. For instance, in July 2022, EMBL-European Bioinformatics Institute (EBI), a part of the European Molecular Biology Laboratory developed AlphaFold, AI system in collaboration with Google DeepMind to provide predictive 3D protein structures. This helps in forecasting of upcoming activities, risk analysis, decision making, and being preemptive for further execution.

    Digital Biomanufacturing Market Opportunity

    Shift Towards Bioprocessing 4.0

    The biopharmaceutical industry is shifting towards Bioprocessing 4.0 (a term derived from Industry 4.0), a national strategic initiative launched by the German government in 2010. Biomanufacturing 4.0 is still in its initial stage. Bioprocessing 4.0 is defined as an end-to-end connected bioprocess, where all equipment and systems in the process are connected digitally through the industrial-internet-of-things (IIoT) to run, control, and enhance processes through feedback loops, machine learning, and artificial intelligence (AI). Digital transformation has become necessary in the biopharmaceutical industry as it provides the competitive advantage and opportunity for streamlining the production process. Digital biomanufacturing uses IoT to connect different data sources, equipment, and materials for process optimization. In combination with digital biomanufacturing solutions the adoption of bioprocessing 4.0 is gradually increasing. Many biopharmaceutical manufactures are shifting towards bioprocessing 4.0 to reduce the manual intervention during drug testing and monitoring which saves time and reduces the risk of errors and cross-contamination, thus boosting production.

    Digital Biomanufacturing Market Analysis: Key Findings

    By Offering: The Software Segment to Dominate the Digital Biomanufacturing Market in 2024

    Based on offering, the digital biomanufacturing market is segmented into software and hardware. In 2024, the software segment is expected to account for the largest share of 74.4% of digital biomanufacturing market. Software used in bioprocessing such as manufacturing execution systems (MES), process analytical technology (PAT), digital twin and data analysis software (DAS) help in designing and planning of drug or biologics from development to manufacturing. The software also provides process monitoring and control with simulation techniques, predictive outcomes, risk analysis, and decision making. The usage of software in the entire biomanufacturing process is contributing to the largest share of the market.

    Additionally, the rising demand of biologics and recent approvals for biologics, increasing R&D activities across biotechnology industry, increasing funding for biopharmaceutical development are supporting the largest share of software.

    By Functionality: The Process Optimization & Analytics Segment to Dominate the Digital Biomanufacturing Market in 2024

    Based on functionality, the digital biomanufacturing market is segmented into product design, process optimization & analytics, automation & control, and other applications. In 2024, the process optimization & analytics segment is expected to account for the largest share of digital biomanufacturing market. Process optimization and analytics technology help biomanufacturing companies in removing halts during the manufacturing process by controlling the parameters such as pH, temperature, and others which affect final quality of product. Process optimization functionalities tools have proven to be beneficial for the biomanufacturers for increasing efficiency and improving product quality, reducing waste, increasing flexibility and profitability. Thus, the adoption of process optimization & analytics solutions is highest among end-users.

    By Bioprocess: The Downstream Bioprocess Segment to Dominate the Digital Biomanufacturing Market, in 2024

    Based on bioprocess, the digital biomanufacturing market is segmented into upstream bioprocess and downstream bioprocess. In 2024, the downstream bioprocess segment is expected to account for the largest share of the digital biomanufacturing market. Downstream bioprocesses are complex and time-consuming activities which delays the product to reach the market. Also, downstream processing is considered as a crucial step for the recovery and purification of biologics. Recovery process can be affected by change in temperature and pH, hence digital biomanufacturing solutions are employed for the real-time monitoring of downstream process. Additionally, digital biomanufacturing solutions provide predictive control over the downstream process by calculating process deviations based on gathered data. Thus, it helps maintaining the stability of the process and accelerates production, hence the demand for digital biomanufacturing in downstream bioprocess is increasing.

    By Application: The Monoclonal Antibodies Segment to Dominate the Digital Biomanufacturing Market in 2024

    Based on application, the digital biomanufacturing market is segmented into monoclonal antibodies, recombinant hormones/proteins, vaccines, cellular-based biologics, and gene-based biologics. In 2024, the monoclonal antibodies segment is expected to account for the largest share of 48.6% of the digital biomanufacturing market. Increasing funding for monoclonal antibody development, increasing approvals for monoclonal antibody, and increasing production capacity of monoclonal antibody are contributing to the largest share of the segment. The diagnostic use of monoclonal antibody has grown over the years owing to the rising number of approvals and increasing manufacturing capacity, and is further expected to increase with the introduction of Bioprocessing 4.0. As Bioprocessing 4.0 uses digital biomanufacturing solutions to run, control, and enhance processes, the manufacturing of monoclonal antibody is expected to increase.

    By End User: The Biopharmaceutical Companies Segment to Dominate the Digital Biomanufacturing Market in 2024

    Based on end-user, the digital biomanufacturing market is segmented into biopharmaceutical companies, academic and research institutes, and CDMO & CROs. In 2024, the biopharmaceutical companies segment is expected to account for the largest share of digital biomanufacturing market. The increasing preference for biopharmaceuticals, increasing research in personalized medicines, and supportive initiatives for the adoption of biopharmaceuticals are supporting the segment’s largest market share. Biopharmaceuticals are typically complex and costlier than the conventional drugs to manufacture. To reduce the errors in manufacturing and scale-up production process, biomanufacturing industries are deploying digital solutions to increase the production of biologics. The increasing number of biopharmaceutical companies along with gradually increasing adoption of digital technologies in biopharmaceutical companies is contributing to the largest share of the segment. For instance, around 55% of companies incorporated digital technologies in the workflow. (Source: Global Pharma Tek, U.S.)

    Geographical Analysis

    North America to Dominate the Market in 2024

    In 2024, North America is expected to account for the largest share of digital biomanufacturing market. The largest share of the region is attributed to the developed healthcare infrastructure, adoption of advanced technologies, and increased investment in biopharmaceutical industry. The presence of key biopharmaceutical companies, contract development, manufacturing firms, and supportive initiatives by government are the key factor contributing to the share of digital biomanufacturing market in North America. Many of the key players are increasing the production capacity of biopharmaceuticals, thus increasing the demand for digital biomanufacturing solutions. For instance, in February 2024 Moderna, Inc. (U.S.), a pharmaceutical and biotechnology company in collaboration with the government of Canada completed the construction of new state-of-the-art mRNA vaccine production facility in Laval, Canada.

    Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 15.1% during the forecast period. The countries in Asia-Pacific, including China, India, and South Korea, are projected to offer significant growth opportunities for the vendors in this market. This is attributed to factors such as the rising number of biopharmaceutical companies, growing patient population, increasing disposable income, and rising foreign direct investments (FDI) for biopharmaceutical companies. In 2015, the Government of China unveiled the Made in China (MIC) 2025 plan aimed at bolstering the country's domestic manufacturing capabilities. This initiative has led to a surge in the emergence of new Chinese biopharmaceutical companies. Besides, China has emerged as an increasingly attractive R&D and manufacturing destination for international pharmaceutical companies trying to shorten product timelines and costs. Thus, the rising investment in the region’s biopharmaceutical industry is increasing the demand for digital biomanufacturing solutions thereby driving the market growth.

    Digital Biomanufacturing Market: Key Companies

    The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2021–2024). The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (Subsidiary of Siemens) (Germany), Cytiva (Subsidiary of Danaher corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing Inc. (U.S.), Schneider Electric SE (France), Dassault Systèmes (France), Oracle Corporation (U.S.), and 3M (U.S.).

    Digital Biomanufacturing Market Overview: Latest Developments from Key Industry Players

    • In February 2023, AVEVA Group Limited (U.K.), launched AVEVA Manufacturing Execution System (MES) 2023, for use in the manufacturing industries for cost effective and time-saving manufacturing process.
    • In December 2022, Tulip Interfaces, Inc. (U.S.), launched cloud-based Manufacturing Execution System (MES) in AWS solutions library to increase flexibility and scalability of the manufacturing process.
    • In February 2022, HCL Technologies Limited (India), launched MVison framework to transform manufacturing processes via automation and digitalization with the help of technologies like augmented reality/virtual reality, connected devices, and artificial intelligence & machine learning.

    Digital Biomanufacturing Market Research Summary

    Particulars

    Details

    Number of Pages

    300

    Format

    PDF

    Forecast Period

    2024-2031

    Base Year

    2023

    CAGR

    13.3%

    Estimated Market Size (Value)

    $50.89 billion by 2031

    Segments Covered

    By Offering

    • Software 
      • By Type
        • Process Analytical Technology
        • Data Analysis Software
        • Manufacturing Execution System
        • Digital Twin 
      • By Deployment
        • Cloud-based
        • On-premise 
    • Hardware

    By Functionality

    • Product Design
    • Process Optimization & analytics
    • Automation & Control
    • Other Functionality
      (Note: Other functionalities include quality management, predictive maintenance, and data storage.)

    By Bioprocess

    • Upstream Bioprocess
    • Downstream Bioprocess

    By Application

    • Monoclonal Antibodies
    • Recombinant Hormones/Proteins
    • Vaccines
    • Cellular-based Biologics
    • Gene-based Biologics

    By End-user

    • Biopharmaceutical Companies
    • Academic and Research Institutes
    • CDMOs & CROs

    Countries Covered

    North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa.

    Key Companies

    The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric Co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing. (U.S.), Schneider Electric SE (France), Dassault Systemes (France), Oracle Corporation (U.S.), and 3M (U.S.).

    Key questions answered in the digital biomanufacturing market report:

    The global digital biomanufacturing market report covers the qualitative and quantitative analysis of the digital biomanufacturing market. This report involves the analysis of various segments of digital biomanufacturing such as offering, functionality, bioprocess, and end-user at the regional and country level. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and Porter’s five forces analysis.

    The global digital biomanufacturing market is projected to reach $50.89 billion by 2031 at a CAGR of 13.3% from 2024 to 2031.

    Among all the offerings studied in this report, the software segment is expected to account for the largest share of 74.4% the digital biomanufacturing market, in 2024. The rising need for process optimization in the biomanufacturing industry is increasing the demand for software. Software deployment helps in evaluating product and process quality with real time monitoring, data management, and prediction-based outcomes. It helps to streamline the process of biomanufacturing.

    The growth of this market can be attributed to several factors such as, growing demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased need for process optimization, increased focus on quality standards & regulatory compliance, strong R&D pipeline for biopharmaceuticals, and rising focus on continuous bioprocessing. However, the excessive cost of technological deployment, complex development, and manufacturing process of biopharmaceuticals are restraining the market growth.

    The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing. (U.S.), Schneider Electric SE (France), Dassault Systems (France), Oracle Corporation (U.S.), and 3M (U.S.).

    The market in Asia-Pacific is slated to register the highest growth rate of 15.1% during the forecast period. The countries in Asia-Pacific, including China, India, and South Korea, are projected to offer significant growth opportunities for the vendors in this market. This is attributed to factors such as the rising number of biopharmaceutical companies, growing patient population, increasing disposable income, and rising foreign direct investments (FDI) for biopharmaceutical companies.

    Enquire
    Check Discount
    COVID-19

    This report provides pre & post COVID-19 market estimates.

    Download sample here
    Related Tag: Digital Biomanufacturing Market Biomanufacturing Smart Biomanufacturing Process Analytical Technology Pharma MES Biologics Manufacturing Digital Manufacturing Digital Twin
    Processing & Packaging Technologies
    Healthcare

    1.  Introduction
        1.1.  Market Definition & Scope
        1.2.  Market Ecosystem
        1.3.  Currency and Limitations
        1.4.  Key Stakeholders
    2.  Research Methodology
        2.1.  Research Approach
        2.2.  Process of Data Collection & Validation
            2.2.1.  Secondary Research
            2.2.2.  Primary Research/Interviews with Key Opinion Leaders from the Industry
        2.3.  Market Sizing and Forecasting
            2.3.1.  Market Size Estimation Approach
            2.3.2.  Growth Forecast Approach
            2.3.3.  Market Share Analysis
        2.4.  Assumptions for the Study
    3.  Executive Summary
    4.  Market Insights
        4.1.  Overview
        4.2.  Drivers
            4.2.1.  Growing Demand for Biologics
            4.2.2.  Capacity Expansions of Biopharmaceutical Plants by Key Players
            4.2.3.  Increased Need for Process Optimization
            4.2.4.  Increased Focus On Quality Standards & Regulatory Compliance
            4.2.5.  Strong R&D Pipeline for Biopharmaceuticals 
            4.2.6.  Rising Focus on Continuous Bioprocessing 
        4.3.  Restraints
            4.3.1.  High Cost of Technology Deployment
            4.3.2.  Complex Development and Manufacturing Process of Biopharmaceuticals 
        4.4.  Opportunities
            4.4.1.  Introduction of Industry 4.0
            4.4.2.  Availability of Advanced Data Analysis Tools
            4.4.3.  Shift Towards Bioprocessing 4.0 
        4.5.  Challenges
            4.5.1.  Complexities in Process Analytical Technology (PAT) Implementation for Downstream Processes.
            4.5.2.  Intensive Capital Requirements for Biopharmaceuticals Production 
        4.6.  Factor Analysis
        4.7.  Trends 
            4.7.1.  Digital Twin Technology
            4.7.2.  Integration of Artificial Intelligence (AI) & Machine Learning (ML)
        4.8.  Regulatory Analysis
        4.9.  Pricing Analysis
        4.10.  Porter’s Five Force Analysis
    5.  Digital Biomanufacturing Market Assessment—by Offering
        5.1.  Overview 
        5.2.  Software
            5.2.1.  By Type
                5.2.1.1.  Process Analytical Technology
                5.2.1.2.  Data Analysis Software
                5.2.1.3.  Manufacturing Execution System
                5.2.1.4.  Digital Twin 
            5.2.2.  By Deployment
                5.2.2.1.  Cloud-based
                5.2.2.2.  On-Premises
        5.3.  Hardware
    6.  Digital Biomanufacturing Market Assessment—by Functionality
        6.1.  Overview
        6.2.  Product Design
        6.3.  Process Optimization & Analytics
        6.4.  Automation & Control
        6.5.  Other Functionalities
    7.  Digital Biomanufacturing Market Assessment—by Bioprocess
        7.1.  Overview
        7.2.  Upstream Bioprocessing
        7.3.  Downstream Bioprocessing
    8.  Digital Biomanufacturing Market Assessment—by Application
        8.1.  Overview
        8.2.  Monoclonal Antibodies
        8.3.  Recombinant Hormones/Proteins
        8.4.  Vaccines
        8.5.  Cellular-based Biologics
        8.6.  Gene-based Biologics
    9.  Digital Biomanufacturing Market Assessment—by End-user 
        9.1.  Overview
        9.2.  Biopharmaceutical Companies
        9.3.  Academic and Research Institutes
        9.4.  CDMOs & CROs
    10.  Digital Biomanufacturing Market Assessment—by Geography
        10.1.  Overview
        10.2.  North America
            10.2.1.  U.S.
            10.2.2.  Canada
        10.3.  Europe
            10.3.1.  Germany
            10.3.2.  France
            10.3.3.  U.K.
            10.3.4.  Italy
            10.3.5.  Spain
            10.3.6.  Switzerland
            10.3.7.  Denmark
            10.3.8.  Ireland
            10.3.9.  Belgium
            10.3.10.  Rest of Europe (RoE)
        10.4.  Asia-Pacific
            10.4.1.  Japan
            10.4.2.  China
            10.4.3.  India
            10.4.4.  South Korea
            10.4.5.  Australia
            10.4.6.  Rest of Asia-Pacific (RoAPAC)
        10.5.  Latin America
            10.5.1.  Brazil
            10.5.2.  Mexico
            10.5.3.  Rest of Latin America (RoLATAM)
        10.6.  Middle East & Africa
    11.  Competition Analysis
        11.1.  Overview
        11.2.  Key Growth Strategies
        11.3.  Competitive Benchmarking
        11.4.  Competitive Dashboard
            11.4.1.  Industry Leaders
            11.4.2.  Market Differentiators
            11.4.3.  Vanguards
            11.4.4.  Emerging Companies
        11.5.  Market Share Analysis/Market Ranking, by Key Players (2023)
    12.  Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
        12.1.  GE Healthcare Technologies, Inc. 
        12.2.  Siemens Xcelerator (subsidiary of Siemens)
        12.3.  Cytiva (subsidiary of Danaher Corporation)
        12.4.  ABB Ltd.  (Sweden)
        12.5.  Sanofi S.A.
        12.6.  Emerson Electric Co.
        12.7.  Honeywell International, Inc.
        12.8.  SAP SE
        12.9.  OVO Biomanufacturing Ltd.
        12.10.  Schneider Electric SE 
        12.11.  Dassault Systèmes
        12.12.  Oracle Corporation
        12.13.  3M
                    (Note: SWOT analysis of the top 5 companies will be provided.)
    13.  Appendix
        13.1.  Available Customization
        13.2.  Related Reports

    List of Tables
    Table 1    Global Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
    Table 2    Global Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 3    Global Digital Biomanufacturing software Market, by Country/Region, 2022–2031 (USD Million)
    Table 4    Global Process Analytical Technology Market, by Country/Region, 2022–2031 (USD Million)
    Table 5    Global Data Analysis Software Market, by Country/Region, 2022–2031 (USD Million)
    Table 6    Global Manufacturing execution System Market, by Country/Region, 2022–2031 (USD Million)
    Table 7    Global Digital Twin Market, by Country/Region, 2022–2031 (USD Million)
    Table 8    Global Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)
    Table 9    Global Cloud-based Digital Biomanufacturing Market, by Country/Region, 2022–2031 (USD Million)
    Table 10    Global On-Premises Digital Biomanufacturing Market, by Country/Region, 2022–2031 (USD Million)
    Table 11    Global Digital Biomanufacturing Hardware Market, by Country/Region, 2022–2031 (USD Million)
    Table 12    Global Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 13    Global Digital Biomanufacturing Market for Product Design Functionality, by Country/Region, 2022–2031 (USD Million)
    Table 14    Global Digital Biomanufacturing Market for Process Optimization & Analytics, by Country/Region, 2022–2031 (USD Million)
    Table 15    Global Digital Biomanufacturing Market for Automation & Control, by Country/Region, 2022–2031 (USD Million)
    Table 16    Global Digital Biomanufacturing Market for Other Functionalities, by Country/Region, 2022–2031 (USD Million)
    Table 17    Global Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 18    Global Digital Biomanufacturing Market for Upstream Bioprocessing, by Country/ Region, 2022–2031 (USD Million)    
    Table 19    Global Digital Biomanufacturing Market for Downstream Bioprocessing, by Country/ Region, 2022–2031 (USD Million)
    Table 20    Global Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 21    Global Digital Biomanufacturing Market for Monoclonal Antibodies, by Country/ Region, 2022–2031 (USD Million)    
    Table 22    Global Digital Biomanufacturing Market for Recombinant Hormones/Proteins, by Country/ Region, 2022–2031 (USD Million)    
    Table 23    Global Digital Biomanufacturing Market for Vaccines, by Country/ Region, 2022–2031 (USD Million)    
    Table 24    Global Digital Biomanufacturing Market for Cellular-based Biologics Market, by Country/ Region, 2022–2031 (USD Million)    
    Table 25    Global Digital Biomanufacturing Market Gene-based Biologics, by Country/ Region, 2022–2031 (USD Million)    
    Table 26    Global Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 27    Global Digital Biomanufacturing Market for Biopharmaceutical Companies, by Country/ Region, 2022–2031 (USD Million)    
    Table 28    Global Digital Biomanufacturing Market for Academic and Research Institutes, by Country/ Region, 2022–2031 (USD Million)    
    Table 29    Global Digital Biomanufacturing Market for CDMOs &CROs, by Country/ Region, 2022–2031 (USD Million)    
    Table 30    Global Digital Biomanufacturing Market, by Country/ Region, 2022–2031 (USD Million)    
    Table 31    North America: Digital Biomanufacturing Market, by Country, 2022-2031 (USD Million)    
    Table 32    North America: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 33    North America: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million
    Table 34    North America: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 35    North America: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 36    North America: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
    Table 37    North America: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
    Table 38    North America: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 39    U.S.: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 40    U.S.: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 41    U.S.: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 42    U.S.: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 43    U.S.: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 44    U.S.: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 45    U.S.: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 46    Canada: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 47    Canada: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 48    Canada: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 49    Canada: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 50    Canada: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 51    Canada: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 52    Canada: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 53    Europe:  Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)    
    Table 54    Europe:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 55    Europe:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 56    Europe:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 57    Europe:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 58    Europe:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 59    Europe:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 60    Europe:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 61    Germany: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 62    Germany: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 63    Germany: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 64    Germany: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 65    Germany: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 66    Germany: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 67    Germany: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 68    U.K.: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 69    U.K.: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 70    U.K.: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 71    U.K.: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 72    U.K.: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 73    U.K.: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 74    U.K.: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 75    Italy: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 76    Italy: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 77    Italy: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 78    Italy: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 79    Italy: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 80    Italy: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 81    Italy: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 82    Spain: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 83    Spain: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 84    Spain: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 85    Spain: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 86    Spain: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 87    Spain: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 88    Spain: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 89    Switzerland: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 90    Switzerland: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 91    Switzerland: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 92    Switzerland: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 93    Switzerland: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 94    Switzerland: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 95    Switzerland: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 96    Denmark: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 97    Denmark: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 98    Denmark: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 99    Denmark: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 100    Denmark: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 101    Denmark: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 102    Denmark: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 103    Ireland: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 104    Ireland: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 105    Ireland: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 106    Ireland: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 107    Ireland: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 108    Ireland: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 109    Ireland: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 110    Belgium: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 111    Belgium: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 112    Belgium: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 113    Belgium: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 114    Belgium: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 115    Belgium: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 116    Belgium: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 117    Rest of Europe: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 118    Rest of Europe: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 119    Rest of Europe: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)    
    Table 120    Rest of Europe: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 121    Rest of Europe: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
    Table 122    Rest of Europe: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
    Table 123    Rest of Europe: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 124    Asia-Pacific: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
    Table 125    Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 126    Asia-Pacific: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 127    Asia-Pacific: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)    
    Table 128    Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 129    Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 130    Asia-Pacific: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 131    Asia-Pacific: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 132    Japan:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 133    Japan:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 134    Japan:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 135    Japan:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 136    Japan:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 137    Japan:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 138    Japan:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 139    China:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 140    China:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 141    China:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 142    China:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 143    China:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 144    China:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 145    China:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 146    India:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 147    India:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 148    India:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 149    India:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 150    India:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 151    India:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 152    India:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 153    Australia:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 154    Australia:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 155    Australia:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)    
    Table 156    Australia:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 157    Australia:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 158    Australia:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 159    Australia:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 160    South Korea:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 161    South Korea:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 162    South Korea:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)    
    Table 163    South Korea:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 164    South Korea:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
    Table 165    South Korea:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
    Table 166    South Korea:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 167    Rest of Asia-Pacific:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
    Table 168    Rest of Asia-Pacific:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 169    Rest of Asia-Pacific:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)    
    Table 170    Rest of Asia-Pacific:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 171    Rest of Asia-Pacific:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 172    Rest of Asia-Pacific:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 173    Rest of Asia-Pacific:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
    Table 174    Latin America: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
    Table 175    Latin America: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 176    Latin America: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
    Table 177    Latin America: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 178    Latin America: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
    Table 179    Latin America: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
    Table 180    Latin America: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
    Table 181    Latin America: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 182    Brazil: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 183    Brazil: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 184    Brazil: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 185    Brazil: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 186    Brazil: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 187    Brazil: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 188    Brazil: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 189    Mexico:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 190    Mexico:  Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)    
    Table 191    Mexico:  Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
    Table 192    Mexico:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 193    Mexico:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 194    Mexico:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 195    Mexico:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 196    Rest of Latin America:  Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)    
    Table 197    Rest of Latin America:  Digital Biomanufacturing Software Market, by Type, 2022–2031 (USD Million)    
    Table 198    Rest of Latin America:  Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)    
    Table 199    Rest of Latin America:  Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 200    Rest of Latin America:  Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 201    Rest of Latin America:  Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 202    Rest of Latin America:  Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)    
    Table 203    Middle East & Africa: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)    
    Table 204    Middle East & Africa: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
    Table 205    Middle East & Africa: Digital Biomanufacturing Software Market, by Type, 2022–2031 (USD Million)
    Table 206    Middle East & Africa: Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)    
    Table 207    Middle East & Africa: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)    
    Table 208    Middle East & Africa: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)    
    Table 209    Middle East & Africa: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)    
    Table 210    Middle East & Africa: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
    Table 211    Recent Developments, by Company, 2021–2024

    List of Figures
    Figure 1    Research Process
    Figure 2    Key Secondary Sources
    Figure 3    Primary Research Techniques
    Figure 4    Key Executives Interviewed
    Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side)
    Figure 6    Market Size Estimation
    Figure 7    Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
    Figure 8    Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
    Figure 9    Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
    Figure 10    Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
    Figure 11    Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
    Figure 12    Global Digital Biomanufacturing Market, by Geography
    Figure 13    Impact Analysis of Market Dynamics
    Figure 14    Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
    Figure 15    Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
    Figure 16    Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
    Figure 17    Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
    Figure 18    Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
    Figure 19    Global Digital Biomanufacturing Market, by Geography, 2024 VS. 2031 (USD Million) 
    Figure 20    North America: Digital Biomanufacturing Market Snapshot
    Figure 21    Europe: Digital Biomanufacturing Market Snapshot
    Figure 22    Asia-Pacific: Digital Biomanufacturing Market Snapshot
    Figure 23    Latin America: Digital Biomanufacturing Market Snapshot
    Figure 24    Key Growth Strategies Adopted by Leading Players, 2021–2024
    Figure 25    Global Digital Biomanufacturing Market: Competitive Benchmarking, by Offering  
    Figure 26    Global Digital Biomanufacturing Market: Competitive Benchmarking, by Geography 
    Figure 27    Global Digital Biomanufacturing Market: Competitive Dashboard
    Figure 28    Global Digital Biomanufacturing Market: Market Share Analysis/Market Ranking, By Key Players (2023)
    Figure 29    GE Healthcare Technologies, Inc.: Financial Snapshot (2023)
    Figure 30    Siemens AG: Financial Snapshot (2023)
    Figure 31    Danaher Corporation: Financial Snapshot (2023)
    Figure 32    ABB Ltd.: Financial Snapshot (2023)
    Figure 33    Sanofi S.A.: Financial Snapshot (2023)
    Figure 34    Emerson Electric co.: Financial Snapshot (2023)
    Figure 35    Honeywell International, Inc.: Financial Snapshot (2023)
    Figure 36    SAP SE: Financial Snapshot (2023)
    Figure 37    Schneider Electric SE: Financial Snapshot (2023)
    Figure 38    Dassault Systèmes: Financial Snapshot (2023)
    Figure 39    Oracle Corporation: Financial Snapshot (2023)
    Figure 40    3M: Financial Snapshot (2023)

    Enquire
    Check Discount
    COVID-19

    This report provides pre & post COVID-19 market estimates.

    Download sample here
    Related Tag: Digital Biomanufacturing Market Biomanufacturing Smart Biomanufacturing Process Analytical Technology Pharma MES Biologics Manufacturing Digital Manufacturing Digital Twin
    Processing & Packaging Technologies
    Healthcare
      This website is secure and we do not share your personal information with any third party. privacy policy
      COVID-19

      This report provides pre & post COVID-19 market estimates.

      Related Tag: Digital Biomanufacturing Market Biomanufacturing Smart Biomanufacturing Process Analytical Technology Pharma MES Biologics Manufacturing Digital Manufacturing Digital Twin
      Request Sample
      Customize My Report
      Linkdin
      Whatsapp
      Feed
      Related Reports
      Digital X-ray Systems Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: Jul-2024

      Digital Health Market - Global Opportunity Analysis and Industry Forecasts (2024-2031)

         Published Date: May-2024

      X-Ray Detectors Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: May-2024

      Digital Therapeutics Market - Global Opportunity Analysis And Industry Forecast (2023-2030)

         Published Date: Jun-2023

      Europe Continuous Bioprocessing Market - Opportunity Analysis And Industry Forecast (2024-2030)

         Published Date: Jul-2024

      Table Of Content
      Download Free Sample Report
      Meticulous Research
      US
      +1 646-781-8004
      Meticulous Research
      Europe
      +44-203-868-8738
      Meticulous Research
      APAC
      +91-744-778-0008